InfuSystem Holdings, Inc.  

(Public, NYSEMKT:INFU)   Watch this stock  
Find more results for NYSEAMEX:INFU
1.60
+0.10 (6.45%)
May 24 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.50 - 1.60
52 week 1.34 - 2.15
Open 1.50
Vol / Avg. 23,946.00/51,700.00
Mkt cap 35.10M
P/E     -
Div/yield     -
EPS -0.12
Shares 21.98M
Beta 0.69
Inst. own 52%
Aug 9, 2013
Q2 2013 InfuSystem Holdings Inc Earnings Release Add to calendar
May 22, 2013
Q1 2013 InfuSystem Holdings Inc Earnings Release
May 14, 2013
Q1 2013 InfuSystem Holdings Inc Earnings Conference Call
Mar 28, 2013
Q4 2012 InfuSystem Holdings Inc Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin 0.23% -83.17%
Operating margin 6.50% -121.45%
EBITD margin - 18.92%
Return on average assets 0.18% -43.99%
Return on average equity 0.34% -72.53%
Employees 185 -
Carbon Disclosure Rating - -

Address

31700 Research Park Drive
MADISON HEIGHTS, MI 48071
United States - Map
+1-248-5467047 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

InfuSystem Holdings, Inc. is a provider of infusion pumps and related services. The Company provides its services to hospitals, oncology practices and facilities and other alternate sites healthcare providers. The Company's core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer. The Company provides these pumps and related supplies to oncology clinics, obtains an assignment of insurance benefits from the patient and bills the patient's insurance company or patient as appropriate, for the use of the pump and supplies, and collect payment. The Company also provides pump management services for the pumps and associated disposable supply kits to approximately 1,400 oncology clinics in the United States.

Officers and directors

Eric Steen Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Jonathan P. Foster Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Janet Skonieczny Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Thomas F. Creal II Executive Vice President - First Biomedical
Age: 65
Bio & Compensation  - Reuters
David M. Haar Senior Vice President - Sales and Marketing
Age: 49
Bio & Compensation  - Reuters
Michael McReynolds Chief Information Officer
Age: 44
Bio & Compensation  - Reuters
Ryan J. Morris Non-Executive Chairman of the Board
Age: 28
Bio & Compensation  - Reuters
David C. Dreyer CPA Independent Director
Age: 55
Bio & Compensation  - Reuters
Joseph E. Whitters Independent Director
Age: 54
Bio & Compensation  - Reuters
Wayne P. Yetter Independent Director
Bio & Compensation  - Reuters